source
- Erasca seeks $550M in public offering to fund KRAS drug developmentErasca announced a public offering targeting $550 million to advance its KRAS-targeted drug program. The biotech said the capital will support ongoing research and potential clinical trials for its…
- AI drug-discovery startup Chai Discovery raises $400 million in Series C, tripling its valuationChai Discovery, a startup focused on using artificial intelligence for drug discovery, announced a new Series C financing round that brought in $400 million. The capital injection was led by existi…